Schizophrenia Research
Volume 115, Issue 2 , Pages 215-221 , December 2009

The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone

  • Isabel Martinez-Gras

      Affiliations

    • Department of Psychiatry. Hospital Universitario 12 de Octubre. Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • Corresponding Author InformationCorresponding author. Servicio de Psiquiatría, Edificio de Medicina Comunitaria, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain. Tel.: +34 91 390 80 19/22; fax: +34 91 390 85 38.
    • ,
  • Gabriel Rubio

      Affiliations

    • Department of Psychiatry. Hospital Universitario 12 de Octubre. Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • ,
  • Blanca Alvarez del Manzano

      Affiliations

    • Department of Psychiatry. Hospital Universitario 12 de Octubre. Madrid, Spain
    • ,
  • Roberto Rodriguez-Jimenez

      Affiliations

    • Department of Psychiatry. Hospital Universitario 12 de Octubre. Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • ,
  • Fernando Garcia-Sanchez

      Affiliations

    • Department of Psychiatry. Hospital Universitario de Móstoles, Madrid, Spain
    • ,
  • Alexandra Bagney

      Affiliations

    • Department of Psychiatry. Hospital Universitario 12 de Octubre. Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • ,
  • Juan Carlos Leza

      Affiliations

    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • Department of Pharmacology. Faculty of Medicine. Complutense University, Madrid, Spain
    • ,
  • José Borrell

      Affiliations

    • Functional and Systems Neurobiology Department, Cajal Institute (CSIC), Madrid, Spain

Received 20 April 2009 ,Revised 12 September 2009 ,Accepted 27 September 2009.

References 

  1. Arnt J, Skarsfeld T. Do novel antipsychotics have similar pharmacological characteristics? A review. Neuropsychopharmacol. 1998;18:63–101
  2. Bakshi VP, Swerdlow NR, Geyer MA. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 1994;271:787–794
  3. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978;15:339–343
  4. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies.. Arch. Gen. Psychiatry. 1990;47(2):181–188
  5. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 1992;49(3):206–215
  6. Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am. J. Psychiatry. 1999;156:596–602
  7. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.). 2001;156:234–258
  8. Braff DL, Light GL, Ellwanger J, Sprock J, Swerdlow NR. Female schizophrenia patients have prepulse inhibition deficits. Biol. Psychiatry. 2005;57:817–820
  9. Butler RW, Braff DL, Rausch J, Jenkins MA, Sprock J, Geyer M. Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related posttraumatic stress disorder. Am. J. Psychiatry. 1990;147:1308–1312
  10. Dawson M, Hazlett E, Filion D, Nuechterlein K, Schell A. Attention and schizophrenia: impaired modulation of the startle reflex. J. Abnorm. Psychology. 1993;102:633–641
  11. Duley AR, Hillman CH, Coombes S, Janelle CM. Sensorimotor gating and anxiety: prepulse inhibition following acute exercise. Int. J. Psychophysiol. 2007;64:157–164
  12. Duncan EJ, Szilagyi S, Efferen TR, Schwartz MP, Parwani A, Chakravorty S, et al Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology (Berl.). 2003;167(1):63–71
  13. Fendt M, Li L, Yeomans JS. Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl.). 2001;156:216–244
  14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P). New York: State Psychiatric Institute, Biometrics Research. 1995;
  15. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl.). 2001;156:117–154
  16. Geyer MA, Ellenbroek B. Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:1071–1079
  17. Grillon C, Ameli R, Charney D, Krystal J, Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry. 1992;32:939–943
  18. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS. Baseline startles amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res. 1996;64:169–117
  19. Grillon C, Dierker L, Merikangas KR. Startle modulation in children at risk for anxiety disorders and/or alcoholism. J. Am. Acad. Child Adolesc. Psych. 1997;36:925–932
  20. Grillon C, Morgan CA, Davis M, Southwick SM. Effect of darkness on acoustic startle in Vietnam veterans with PTSD. Am. J. Psychiatry. 1998;155:812–817
  21. Hamm AO, Weike AI, Schupp HT. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology (Berl.). 2001;156:259–265
  22. Hazlett EA, Romero MJ, Haznedar MM, New AS, Goldstein KE, Newmark RE, et al. Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr. Res. 2007;93:288–295
  23. Hazlett EA, Buchsbaum MS, Zhang J, Newmark RE, Glanton CF, Zelmanova Y, et al. Frontal–striatal–thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage. 2008;42:1164–1177
  24. Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive–compulsive disorder Biol. Psychiatry. 2005;57:1153–1158
  25. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SCR, Sharma T. Differences in frontal cortical activation by a working memory task following substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc. Natl Acad. Sci. USA. 1999;96:13432–13437
  26. Ichikawa J, Meltzer HY. Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249(suppl. 4):90–98
  27. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–275
  28. Keith VA, Mansbach RS, Geyer MA. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol. Psychiatry. 1991;30:557–566
  29. Koch M. The neurobiology of startle. Prog. Neurobiol. 1999;59:107–128
  30. Koch M, Bubser M. Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur. J. NeuroSci. 1994;6:1837–1845
  31. Kumari V, Soni W, Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am. J. Psychiatry. 1999;156(7):1046–1051
  32. Kumari V, Soni W, Mathew VM, Sharma T. Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch. Gen. Psychiatry. 2000;57:609–614
  33. Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl.). 2002;162:97–101
  34. Kumari V, Soni W, Sharma T. Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophr. Res. 2002;55:139–146
  35. Kumari V, Aasen I, Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr. Res. 2004;69:219–235
  36. Kumari V, Fannon D, Sumich AL, Sharma T. Startle gating in antipsychotic–naïve first episode schizophrenia patients: one ear is better than two. Psychiatry Res. 2007;151:21–28
  37. Kunugi H, Tanaka M, Hori H, Hashimoto R, Saitoh O, Hironaka N. Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia. Neurosci. Res. 2007;59:23–28
  38. Lang PJ, Davis M, Öhman A. Fear and anxiety: animal models and human cognitive psychophysiology. J. Affect. Disord. 2000;61(3):137–159
  39. Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002;27:1–11
  40. Leumann L, Feldon J, Vollenweider FX, Ludewig K. Effects of typical and atypical antipsychotics on prepulse inhibition and inhibition in chronic schizophrenia. Biol. Psychiatry. 2002;52(7):729–739
  41. Lipschitz DS, Mayes LM, Rasmusson AM, Anyan W, Billingslea E, Gueorguieva R, et al. Baseline and modulated acoustic startle responses in adolescent girls with posttraumatic stress disorder. J. Am. Acad. Child Adolesc. Psych. 2005;44(8):807–814
  42. Ludewig K, Geyer MA, Etzensberger M, Vollenweider FX. Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr. Res. 2002;55:129–137
  43. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Prepulse inhibition deficits in patients with panic disorder. Depress. Anxiety. 2002;15(2):55–60
  44. Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J. Psychiatry Neurosci. 2005;30(1):37–43
  45. Mackeprang T, Kristiansen KT, Glenthoj BY. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol. Psychiatry. 2002;52(9):863–873
  46. Mansbach RS, Geyer MA, Braff DL. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 1988;94:507–514
  47. Mayer AR, Hanlon FM, Franco AR, Toshiba TM, Thoma RJ, Clark VP, et al. The neural networks underlying auditory sensory gating. Neuroimage. 2009;44:182–189
  48. Meincke U, Light GA, Geyer MA, Braff DL, Gouzoulis-Mayfrank E. Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Res. 2004;126:51–61
  49. Meltzer HY, Park S, Kessler R. Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl Acad. Sci. USA. 1999;96:13591–13593
  50. Minassian A, Feifel D, Perry W. The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr. Res. 2007;89:225–231
  51. Moller HJ. Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences. World J. Biol. Psychiatry. 2000;1:75–91
  52. Morgan CA, Grillon C, Southwick SM, Davis M, Charney DS. Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder. Am. J. Psychiatry. 1996;153:64–68
  53. Morgan CA, Grillon C, Lubin H, Southwick SM. Startle reflex abnormalities in women with sexual assault — related posttraumatic stress disorder. Am. J. Psychiatry. 1997;154:1076–1080
  54. Oranje B, Van Oel CJ, Gispen-De Wied CC, Verbaten MN, Kahn RS. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J. Clin. Psychopharmacol. 2002;22(4):359–365
  55. Ornitz EM, Pynoos RS. Startle modulation in children with posttraumatic stress disorder. Am. J. Psychiatry. 1989;146:866–870
  56. Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R, et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol. Psychiatry. 2000;47:662–669
  57. Perry W, Braff DL. Information-processing deficits and thought disorder in schizophrenia. Am. J. Psychiatry. 1994;151:363–367
  58. Perry W, Geyer MA, Braff DL. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch. Gen. Psychiatry. 1999;56:277–281
  59. Perry W, Feifel D, Minassian A, Bhattacharjie I, Braff DL. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am. J. Psychiatry. 2002;159(8):1375–1381
  60. Pycock CV, Kervin RW, Carter CJ. Effects of lesions of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980;286:74–77
  61. Quednow BB, Wagner M, Westheide J, Beckmann K, Bliesener N, Maier W, et al. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol. Psychiatry. 2006;59(6):536–545
  62. Quednow BB, Frommann I, Berning J, Kühn KU, Maier W, Wagner M. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol. Psychiatry. 2008;64(9):766–773
  63. Remington G, Kapur S. Atypical antipsychotics: are some more atypical than others?. Psychopharmacology. 2000;148:3–15
  64. Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Gompel P, Lesage AS, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl.). 1996;124:57–73
  65. Swerdlow NR, Masten V, Geyer MA, Braff DL. Schizophrenic like abnormalities in sensory gating following accumbens dopamine infusions in rats. Psychopharmacology (Berl). 1990;101:414–420
  66. Swerdlow NR, Keith VA, Braff DL, Geyer MA. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J. Pharmacol. Exp. Ther. 1991;256:530–536
  67. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol. Psychiatry. 1993;33:298–301
  68. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry. 1994;51:139–154
  69. Swerdlow NR, Hartston HJ, Zinner S. Sensorimotor gating deficits in obsessive compulsive disorder (OCD): lateralized findings. Biol. Psychiatry. 1997;41:83S
  70. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 1998;24:285–301
  71. Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.). 2001;156:194–215
  72. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch. Gen. Psychiatry. 2006;63(12):1325–1335
  73. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl.). 2008;199:331–388
  74. Weike AI, Bauer U, Hamm AO. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol. Psychiatry. 2000;47(1):61–70
  75. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 1987;44:660–669
  76. Wynn JK, Dawson ME, Schell AM, McGee M, Salveson D, Green MF. Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol. Psychiatry. 2004;55:518–523
  77. Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, et al. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr. Res. 2007;95:134–142
  78. Yoshimura R, Nakamura J, Ueda N, Terao T. Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement. Int. Clin. Psychopharmacol. 2000;15:175–180

PII: S0920-9964(09)00479-4

doi: 10.1016/j.schres.2009.09.035

Schizophrenia Research
Volume 115, Issue 2 , Pages 215-221 , December 2009

Article Tools